PT Indofarma Tbk (IDX:INAF)
126.00
0.00 (0.00%)
Jul 1, 2024, 2:55 PM WIB
PT Indofarma Tbk Revenue
PT Indofarma Tbk had revenue of 25.72B IDR in the quarter ending June 30, 2026, a decrease of -15.03%. This brings the company's revenue in the last twelve months to 163.57B, down -2.46% year-over-year. In the year 2025, PT Indofarma Tbk had annual revenue of 151.55B, down -27.96%.
Revenue (ttm)
163.57B
Revenue Growth
-2.46%
P/S Ratio
2.39
Revenue / Employee
3.89B
Employees
42
Market Cap
390.51B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 151.55B | -58.83B | -27.96% |
| Dec 31, 2024 | 210.38B | -313.22B | -59.82% |
| Dec 31, 2023 | 523.60B | -456.77B | -46.59% |
| Dec 31, 2022 | 980.37B | -1,921.62B | -66.22% |
| Dec 31, 2021 | 2.90T | 1.19T | 69.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 37.72T |
| PT Siloam International Hospitals Tbk | 13.51T |
| PT Mitra Keluarga Karyasehat Tbk | 5.57T |
| PT. Penta Valent Tbk | 3.70T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.70T |
| PT Ikapharmindo Putramas Tbk | 400.25B |
| PT Royal Prima Tbk | 320.78B |
| PT Diastika Biotekindo Tbk | 205.27B |